Turudic, D.; Pokrajac, D.; Tasic, V.; Kasumovic, D.; Prohaszka, Z.; Milosevic, D.
The Rationale of Complement Blockade of the MCPggaac Haplotype following Atypical Hemolytic Uremic Syndrome of Three Southeastern European Countries with a Literature Review. Int. J. Mol. Sci. 2023, 24, 13041.
https://doi.org/10.3390/ijms241713041
AMA Style
Turudic D, Pokrajac D, Tasic V, Kasumovic D, Prohaszka Z, Milosevic D.
The Rationale of Complement Blockade of the MCPggaac Haplotype following Atypical Hemolytic Uremic Syndrome of Three Southeastern European Countries with a Literature Review. International Journal of Molecular Sciences. 2023; 24(17):13041.
https://doi.org/10.3390/ijms241713041
Chicago/Turabian Style
Turudic, Daniel, Danka Pokrajac, Velibor Tasic, Dino Kasumovic, Zoltan Prohaszka, and Danko Milosevic.
2023. "The Rationale of Complement Blockade of the MCPggaac Haplotype following Atypical Hemolytic Uremic Syndrome of Three Southeastern European Countries with a Literature Review" International Journal of Molecular Sciences 24, no. 17: 13041.
https://doi.org/10.3390/ijms241713041
APA Style
Turudic, D., Pokrajac, D., Tasic, V., Kasumovic, D., Prohaszka, Z., & Milosevic, D.
(2023). The Rationale of Complement Blockade of the MCPggaac Haplotype following Atypical Hemolytic Uremic Syndrome of Three Southeastern European Countries with a Literature Review. International Journal of Molecular Sciences, 24(17), 13041.
https://doi.org/10.3390/ijms241713041
